THE DIGITAL PATHOLOGY MARKET IS AT AN INFLECTION POINT, AND TEMPUS’ RECENT $81.25 MILLION ACQUISITION OF PAIGE underscores both the challenges and opportunities ahead. While the pandemic temporarily accelerated digital pathology adoption, with vendors raising large sums on the promise of artificial intelligence (AI)-powered diagnostics and remote workflows, the realities of cost, reimbursement hurdles, workflow […]
Deal Offers Signals about the Future of Digital Pathology
Analyst Imogen Fitt notes that Tempus’ $81 million acquisition of Paige serves as a market correction
- By Janette Wider
- > From the Volume XXXII, No. 13 - September 15, 2025 Issue
- Tags: AI, AI Playground, Andy Moye, ArteraAI, artificial intelligence, College of American Pathologists, COVID-19, digital pathology, DP, Eric Lefkofsky, Imagene AI, Imogen Fitt, molecular diagnostics, Natera, Paige, pandemic, precision medicine, Razik Yousfi, Signify Research, Tempus, whole slide imaging
